181 results on '"Levey, Andrew S"'
Search Results
2. Serum Metabolomic Markers of Protein-Rich Foods and Incident CKD: Results From the Atherosclerosis Risk in Communities Study
3. Evaluation of novel candidate filtration markers from a global metabolomic discovery for glomerular filtration rate estimation
4. Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review
5. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
6. Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR
7. Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS
8. Discordances Between Creatinine and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
9. A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors
10. A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease
11. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
12. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
13. Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians
14. Cystatin C and Muscle Mass in Patients With Heart Failure
15. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
16. Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric Surgery
17. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
18. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
19. GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing
20. Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients
21. Estimating glomerular filtration rate in kidney transplant recipients: considerations for selecting equations
22. Estimated Glomerular Filtration Rate From a Panel of Filtration Markers—Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate?
23. Measurement and Estimation of Residual Kidney Function in Patients on Dialysis
24. Performance of GFR Estimating Equations in Young Adults
25. Impact of Using the Race-Free 2021 CKD-EPI Creatinine Equation on Treatment Effects on GFR-Based End Points in Clinical Trials
26. 116 - Chronic Kidney Disease
27. 3 - Assessment of Glomerular Filtration Rate
28. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD
29. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
30. DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease
31. Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis
32. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis
33. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
34. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study
35. Biomarkers of Vitamin D Status and Risk of ESRD
36. GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD
37. A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil
38. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
39. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
40. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
41. Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort
42. Filtration Markers as Predictors of ESRD and Mortality in Southwestern American Indians With Type 2 Diabetes
43. Segmental Kidney Volumes Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Their Association With CKD in Older People
44. Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting
45. Utility and Validity of Estimated GFR–Based Surrogate Time-to-Event End Points in CKD: A Simulation Study
46. GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
47. GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials
48. GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
49. Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
50. Performance of Creatinine-Based GFR Estimating Equations in Solid-Organ Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.